Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Su-Yun Xiang"'
Autor:
Su-Yun Xiang, Jia-Hui Sun, Shu-Qin Yu, Shao-Jie Huo, Meng-Yuan Hu, Chong Ye, Yi-Zhen Yuan, Yu-Ting Zhu
Publikováno v:
Toxicology and applied pharmacology. 434
Di(2-ethylhexyl) phthalate (DEHP) belongs to environmental endocrine disrupting chemicals (EEDCs) and can be rapidly hydrolyzed into the ultimate toxicant mono-2-ethylhexyl phthalate (MEHP). In this study, we used 5-aminofluorescein modified MEHP (ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568696ac11deb7ecf2c7dd92598a2070
https://pubmed.ncbi.nlm.nih.gov/34843800
https://pubmed.ncbi.nlm.nih.gov/34843800
Autor:
Ling-Ling Zhang, Shao-Jie Huo, Su-Yun Xiang, Xiu Wu, Shu-Qin Yu, Meng-Yuan Hu, Chong Ye, Wen-Jie Li
Publikováno v:
Chemical Research in Toxicology. 32:2006-2015
In this study, we synthesized a small molecule fluorescent probe for detecting mono-2-ethylhexyl phthalate (MEHP) named MEHP-AF, which formed by MEHP cross-linked with 5-aminofluorescein (5-AF) through amide bond. MEHP-AF had been purified based on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1249d3269694ff01144398698fc9f8
https://doi.org/10.1021/acs.chemrestox.9b00191
https://doi.org/10.1021/acs.chemrestox.9b00191
Autor:
Xiu Wu, Shu-Qin Yu, Qiu-Ping Feng, Wen-Jie Li, Yi-Zhen Yuan, Meng-Yuan Hu, Su-Yun Xiang, Yu-Ting Zhu
Publikováno v:
Toxicology and applied pharmacology. 414
Di-2-ethylhexyl phosphate (DEHP) and its main toxic metabolite mono-2-ethylhexyl phthalate (MEHP) are the typical endocrine disrupting chemicals (EDCs) and widely affect human health. Our previous research reported that synthetic nonionic dietary emu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455cb1a077616a31959f658b3854bea8
https://pubmed.ncbi.nlm.nih.gov/33476678
https://pubmed.ncbi.nlm.nih.gov/33476678
Autor:
Chong Ye, Xiu Wu, Meng-Yuan Hu, Wen-Jie Li, Hao-Han Yu, Yu-Ting Zhu, Qiu-Ping Feng, Shu-Qin Yu, Su-Yun Xiang
Publikováno v:
Materials scienceengineering. C, Materials for biological applications. 117
Although combined chemotherapy had achieved the ideal efficacy in clinical anti-cancer therapeutic, the issues that need to be addressed are non-targeting and toxic-side effects of small molecule chemical drug (SMCD). In this study, we designed and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71678412cf8c1d99fb0ceb05facffebe
https://pubmed.ncbi.nlm.nih.gov/32919698
https://pubmed.ncbi.nlm.nih.gov/32919698
Autor:
Hao-Han Yu, Chong Ye, Ling-Ling Zhang, Jia-Hui Sun, Shu-Qin Yu, En-He Bai, Shao-Jie Huo, Su-Yun Xiang
Publikováno v:
Nanotechnology. 30(8)
To increase the efficacy of small molecule chemotherapeutic drug (SMCD) and reduce its toxic and side effects, we selected two model drugs doxorubicin (DOX) and chloroquine (CQ). DOX is a SMCD and CQis a chemosensitizer with autophagy inhibition. Pol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6cbd8ae7f11315027f58084bcf71be
https://pubmed.ncbi.nlm.nih.gov/30523865
https://pubmed.ncbi.nlm.nih.gov/30523865
Autor:
Yi-Zhen Yuan, Qiu-Ping Feng, Wen-Jie Li, Hao-Han Yu, Su-Yun Xiang, Yu-Ting Zhu, Meng-Yuan Hu, Shu-Qin Yu
Publikováno v:
Materials Science and Engineering: C. 124:112039
In this study, to improve the intestinal absorption of small molecule chemotherapeutic drug docetaxel (DTX) and macromolecular monoclonal antibody drug bevacizumab (BVZ), we designed and prepared a type of co-delivery nanoparticles for the oral admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b01623713686a99f2b4c6afb2a44fcb6
https://doi.org/10.1016/j.msec.2021.112039
https://doi.org/10.1016/j.msec.2021.112039
Autor:
Jia-Hui Sun, Chong Ye, En-He Bai, Ling-Ling Zhang, Shao-Jie Huo, Hao-Han Yu, Su-Yun Xiang, Shu-Qin Yu
Publikováno v:
Nanotechnology; 2/22/2019, Vol. 30 Issue 8, p1-1, 1p